Perioperative haemostasis with full‐length, PEGylated, recombinant factor VIII with extended half‐life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single‐arm phase III trial

INTRODUCTION: Rurioctocog alfa pegol (BAX 855, TAK‐660) is a PEGylated, full‐length, recombinant factor VIII (rFVIII) with extended half‐life developed from unmodified rFVIII (antihaemophilic factor [recombinant]). AIM: To determine the perioperative haemostatic efficacy and safety of rurioctocog al...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Haemophilia
Autores principales: Gruppo, Ralph, López‐Fernández, Maria‐Fernanda, Wynn, Tung T., Engl, Werner, Sharkhawy, Marlies, Tangada, Srilatha
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852556/
https://ncbi.nlm.nih.gov/pubmed/31353761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13807
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares